Healthcare Media & Clinician Networks · vs · Publisher Inventory Monetisation & Yield
Doceree vs Equativ
Structured technology and market comparison · 2026
Direct Feature Comparison
Doceree · vs · Equativ| Attribute | ||
|---|---|---|
| Market Cluster / Sector | Healthcare Media & Clinician Networks | Publisher Inventory Monetisation & Yield |
| Business Model / Role | AdTech Vendor · Publisher & Media Owner | AdTech Vendor · Data Provider / Broker |
| Platform Focus | Healthcare adtech platform for pharma, publishers and HCP targeting. | Programmatic adtech platform spanning SSP, DSP, retail media and CTV. |
| Company Size | 201–500 employees | 501–1,000 employees |
| Headquarters | United States | France |
| Year Founded | 2020 | 2012 |
| Dossier & Alternatives |
Analyze all overlapping signals and tech stacks for Doceree and Equativ
Compare mutual enterprise clients, monetization models, live market signals, and partner networks directly in the interactive Knowledge Graph.
Comparison Analysis
What is the main difference between Doceree and Equativ?
When comparing Doceree and Equativ, both platforms operate within the Demand-Side Platform (DSP), In-App, and Display Ads & Banner ecosystem. Doceree is positioned as Healthcare adtech platform for pharma, publishers and HCP targeting, whereas Equativ focuses on Programmatic adtech platform spanning SSP, DSP, retail media and CTV. Decision-makers evaluate both solutions when orchestrating their commercial monetization and technology stack.
What are the top alternatives to Doceree and Equativ?
When evaluating Doceree and Equativ, enterprise buyers also consider other platforms in Demand-Side Platform (DSP), In-App, and Display Ads & Banner. You can discover the full competitive landscape and evaluate other alternatives by viewing their respective footprint profiles on Polaris7.
How do the corporate scale, structure, and headquarters of Doceree and Equativ compare?
Doceree is headquartered in United States (founded in 2020) with 201–500 employees. Equativ is based in France (founded in 2012) with 501–1,000 employees. Complete ownership, subsidiary trees, and corporate affiliations are documented across Polaris7.
Market Signals
Recent Market Signals & Activity: Doceree vs Equativ
Documented market movements, strategic partnerships, product releases, and regulatory developments mapped across Polaris7.
Doceree
Recent Signals
- ·DocereeProduct & Platform Launch
Real Time HCP Targeting: How Fast Should Pharma Act on Clinical Intent Signals?
Doceree's article argues that real-time HCP targeting should be measured by signal-to-exposure time, not just data freshness. It outlines four latency stages—signal detection, verified HCP identity, signal-to-activation, and activation-to-exposure—and recommends specific metrics for pharma teams. Doceree's Clinical Intent Signals combine EHR activity, prescribing behavior, and point-of-care context with verified provider identity for NPI-level targeting. Its Intent Powered HCP Suite activates these signals across point of care, programmatic, social, and CTV.
- Doceree defines real-time HCP targeting as the time between a clinical event and the first relevant HCP exposure, not merely signal processing time.
- The clinical signal path includes clinical activity → signal detection → HCP identification → audience activation → ad delivery, with potential latency at each stage.
- Doceree's Clinical Intent Signals use EHR activity, prescribing behavior, point-of-care context, and other decision-moment signals, combined with verified provider identity for NPI-level targeting.
- ·DocereeProduct & Platform Launch
Highlights of the Fierce Pharma Week 2026
On September 14, 2026, Doceree launched its Intent-Powered HCP Suite with a rooftop event and a 300-drone show over Philadelphia, followed by a three-day presence at Fierce Pharma Week 2026. The launch featured the new Daily Command decision layer and extended real-time clinical intent orchestration to CTV, social, and programmatic, alongside existing point-of-care and DOOH channels. During the week, Harshit Jain held a fireside chat with Maria Menounos on clinical intent, and Doceree hosted sessions on agentic AI and reaching all three moments of the prescription journey.
- On September 14, 2026, Doceree hosted a Rooftop Social at Assembly Rooftop Lounge at The Logan Hotel in Philadelphia and launched its Intent-Powered HCP Suite with a 300-drone show over the city.
- The drone show spelled 'Clinical Intent Signals' and 'Understand every intent. Improve every outcome.' above Philadelphia.
- The Intent-Powered HCP Suite extends real-time clinical intent orchestration to CTV, Social, and Programmatic, complementing existing Care Sequence, DOOH, and Point of Care channels.
Equativ
Recent Signals
- ·SharethroughProduct & Platform Launch
Brand Safety in 2026: How AI Content Placement Shapes Trust
Equativ published new research on November 9, 2026, revealing that 80% of US and Canadian consumers are not very confident in their ability to identify AI-generated content, with 55% citing AI-generated fake news or deepfakes as their top concern. The survey of 1,000 consumers found that 44% would think less of a brand if its ad appeared on a website with mostly AI-written articles, with younger adults (18-34) being the most critical. Additionally, 67% of consumers are uncomfortable with websites using their personal data to power AI features. Equativ recommends brands audit ad placements, buy curated inventory, and ensure transparent data use, highlighting its own actions such as banning made-for-advertising sites and integrating DoubleVerify's quality controls.
- 80% of US and Canadian consumers are not very confident in identifying AI-generated content.
- 55% of consumers named AI-generated fake news or deepfakes as their top AI risk concern.
- 44% of consumers would think less of a brand if its ad appeared on a site with mostly AI-written articles.
- ·EquativProduct & Platform Launch
Holiday Shoppers Are Embracing AI. Here's What Still Wins Them Over.
According to Equativ's September 2026 survey of 1,000 shoppers across the U.S. and Canada, consumer use of AI assistants for holiday shopping has doubled year-over-year from 32% in 2025 to 66% in 2026. However, consumers primarily use AI late in the purchase journey for comparing prices and finding deals, while traditional discovery methods like in-store browsing (57%) and friends and family (51%) still lead. Furthermore, consumer sentiment toward visible AI-generated creative in ads skews negative, with 44% of 18-to-24-year-olds reporting a worse perception of brands using visible AI imagery.
- Equativ surveyed 1,000 adult shoppers in the U.S. and Canada in September 2026, comparing results against September 2025 benchmarks.
- 66% of shoppers reported using an AI assistant to find gift ideas or compare prices in 2026, up from 32% in 2025, with adoption reaching 75% among consumers under 45.
- For gift inspiration and options comparison, in-store browsing (57%), friends and family (51%), and search engines (45%) still rank ahead of AI assistants (34%).
- ·EquativProduct & Platform Launch
Programmatic Guaranteed vs PMP: Which Deal Wins?
Equativ has published an analytical guide comparing Programmatic Guaranteed (PG) and Private Marketplace (PMP) deal structures across connected TV, live sports, and retail media. The analysis contrasts PG's reserved inventory and delivery certainty with the auction-based flexibility and optimization potential of PMPs. Additionally, the guide highlights the role of curated PMPs, including GreenPMPs, in refining audience targeting, performance, and sustainability.
- Programmatic Guaranteed offers fixed pre-negotiated pricing and reserved inventory, making it suitable for tentpole moments and fixed campaign windows.
- Private Marketplaces operate via invitation-only auctions without delivery guarantees, allowing buyers to adjust bids and optimize mid-flight.
- A cited CTV campaign using Guaranteed Auction Packages reached a 93.44% VTR and approximately 100% on-time impression delivery.
Start with a company or market. Track what changes.
Create your Polaris7 workspace to explore extended company profiles, organize relevant players into Watchlists, and receive focused briefings when material changes occur.
Doceree vs. Equativ
Compare capabilities, ecosystem relationships, and recent signals side by side in Polaris7.
Company Comparisons
Compare capabilities, ecosystem relationships, and recent signals side by side in Polaris7.
